Federal Register: Determination of Regulatory Review Period for Purposes of Patent Extension; TUDORZA PRESSAIR

The FDA has determined the regulatory review period for TUDORZA PRESSAIR and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent...
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Equipment Source Type: news